AFATINIB
DESCRIPTION :
Afatinib is used to treat metastatic non-small cell lung cancer (NSCLC) that has certain EGFR mutations (exon 19 deletion/exon 21 substitution) as detected by an FDA-approved test..AFATINIB WORKS AS :
Afatinib is designed to block tumor cell growth in several ways. Afatinib blocks the activating sites (called tyrosine kinases) of several proteins within the cell. These proteins are most likely to stimulate cancer growth when the tumor contains the EGFR gene mutation. By blocking these targets, it is hoped the cancer will shrink.USES OF AFATINIB :
Afatinib is used to treat a certain type of lung cancer (non-small cell lung cancer) that has spread to other parts of the body. It belongs to a class of drugs known as kinase inhibitors.FEATURES OF AFATINIB :
Afatinib oral tablet is available as a brand-name drug. It’s not available as a generic drug.Afatinib is used to treat non-small cell lung cancer. (NSCLC) that’s metastatic. Metastatic means the cancer has spread from your lungs to other parts of your body.
THE BRANDS ARE AVAILABLE IN AFATINIB :
- XOVOLTIB 20MG
- XOVOLTIB 30MG
- XOVOLTIB 40MG
- XOVOLTIB 50MG
MECHANISM OF ACTION :
MISSED DOSE :
If patient missed to take the dose of Xovoltib the missed dose should be skipped and follow the regular dosing schedule. Do not self-medicate. Do not double the dose.
FOR MORE INFORMATION :
Call us : 91-9987711567
Mail to : applepharmaaceutical@gmail.com
nice blog to follow and get pharmaceutical related general kdge ! keep it up !
ReplyDelete